Tobias Borgtoft Bergmann

Tobias Borgtoft Bergmann

Auto-generated profile, based on publicly available information

Tobias Borgtoft Bergmann

University of Copenhagen, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2020 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
RYRafael Yuste
Rafael Yuste
MHMichael Hawrylycz
Michael Hawrylycz
NANadia Aalling
Nadia Aalling
AAArgel Aguilar-Valles
Argel Aguilar-Valles
DADetlev Arendt
Detlev Arendt
ELEd Lein
Ed Lein
To understand the function of cortical circuits, it is necessary to catalog their cellular diversity. Past attempts to do so using anatomical, physiological or molecular features of cortical cells have not resulted in a unified taxonomy of neuronal or glial cell types, partly due to limited data. Single-cell transcriptomics is enabling, for the first time, systematic high-throughput measurements of cortical cells and generation of datasets that hold the promise of being complete, accurate and permanent. Statistical analyses of these data reveal clusters that often correspond to cell types previously defined by morphological or physiological criteria and that appear conserved across cortical areas and species. To capitalize on these new methods, we propose the adoption of a transcriptome-based taxonomy of cell types for mammalian neocortex. This classification should be hierarchical and use a standardized nomenclature. It should be based on a probabilistic definition of a cell type and incorporate data from different approaches, developmental stages and species. A community-based classification and data aggregation model, such as a knowledge graph, could provide a common foundation for the study of cortical circuits. This community-based classification, nomenclature and data aggregation could serve as an example for cell type atlases in other parts of the body.

15 January 2019 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
AFAmilcar Flores-Morales
Amilcar Flores-Morales
TBTobias B. Bergmann
Tobias B. Bergmann
CLCharlotte Lavallee
Charlotte Lavallee
TBTanveer S. Batth
Tanveer S. Batth
DLDong Lin
Dong Lin
DIDiego Iglesias-Gato
Diego Iglesias-Gato
Purpose: An increasing number of castration-resistant prostate cancer (CRPC) tumors exhibit neuroendocrine (NE) features. NE prostate cancer (NEPC) has poor prognosis, and its development is poorly understood. Experimental Design: We applied mass spectrometry–based proteomics to a unique set of 17 prostate cancer patient–derived xenografts (PDX) to characterize the effects of castration in vivo, and the proteome differences between NEPC and prostate adenocarcinomas. Genome-wide profiling of REST-occupied regions in prostate cancer cells was correlated to the expression changes in vivo to investigate the role of the transcriptional repressor REST in castration-induced NEPC differentiation. Results: An average of 4,881 proteins were identified and quantified from each PDX. Proteins related to neurogenesis, cell-cycle regulation, and DNA repair were found upregulated and elevated in NEPC, while the reduced levels of proteins involved in mitochondrial functions suggested a prevalent glycolytic metabolism of NEPC tumors. Integration of the REST chromatin bound regions with expression changes indicated a direct role of REST in regulating neuronal gene expression in prostate cancer cells. Mechanistically, depletion of REST led to cell-cycle arrest in G1, which could be rescued by p53 knockdown. Finally, the expression of the REST-regulated gene secretagogin (SCGN) correlated with an increased risk of suffering disease relapse after radical prostatectomy. Conclusions: This study presents the first deep characterization of the proteome of NEPC and suggests that concomitant inhibition of REST and the p53 pathway would promote NEPC. We also identify SCGN as a novel prognostic marker in prostate cancer.

4 December 2020 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
RYRafael Yuste
Rafael Yuste
MHMichael Hawrylycz
Michael Hawrylycz
NANadia Aalling
Nadia Aalling
AAArgel Aguilar-Valles
Argel Aguilar-Valles
DADetlev Arendt
Detlev Arendt
ELEd Lein
Ed Lein

19 March 2021 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
RYRafael Yuste
Rafael Yuste
MHMichael Hawrylycz
Michael Hawrylycz
NANadia Aalling
Nadia Aalling
AAArgel Aguilar-Valles
Argel Aguilar-Valles
DADetlev Arendt
Detlev Arendt
ELEd Lein
Ed Lein
A Correction to this paper has been published: https://doi.org/10.1038/s41593-020-00779-0.

31 March 2023
Verified
Other
Open access
AFAmilcar Flores-Morales
Amilcar Flores-Morales
TBTobias B. Bergmann
Tobias B. Bergmann
CLCharlotte Lavallee
Charlotte Lavallee
TBTanveer S. Batth
Tanveer S. Batth
DLDong Lin
Dong Lin
DIDiego Iglesias-Gato
Diego Iglesias-Gato

31 March 2023
Verified
Other
Open access
AFAmilcar Flores-Morales
Amilcar Flores-Morales
TBTobias B. Bergmann
Tobias B. Bergmann
CLCharlotte Lavallee
Charlotte Lavallee
TBTanveer S. Batth
Tanveer S. Batth
DLDong Lin
Dong Lin
DIDiego Iglesias-Gato
Diego Iglesias-Gato
Purpose:An increasing number of castration-resistant prostate cancer (CRPC) tumors exhibit neuroendocrine (NE) features. NE prostate cancer (NEPC) has poor prognosis, and its development is poorly understood.Experimental Design: We applied mass spectrometry–based proteomics to a unique set of 17 prostate cancer patient–derived xenografts (PDX) to characterize the effects of castration in vivo, and the proteome differences between NEPC and prostate adenocarcinomas. Genome-wide profiling of REST-occupied regions in prostate cancer cells was correlated to the expression changes in vivo to investigate the role of the transcriptional repressor REST in castration-induced NEPC differentiation.Results:An average of 4,881 proteins were identified and quantified from each PDX. Proteins related to neurogenesis, cell-cycle regulation, and DNA repair were found upregulated and elevated in NEPC, while the reduced levels of proteins involved in mitochondrial functions suggested a prevalent glycolytic metabolism of NEPC tumors. Integration of the REST chromatin bound regions with expression changes indicated a direct role of REST in regulating neuronal gene expression in prostate cancer cells. Mechanistically, depletion of REST led to cell-cycle arrest in G1, which could be rescued by p53 knockdown. Finally, the expression of the REST-regulated gene secretagogin (SCGN) correlated with an increased risk of suffering disease relapse after radical prostatectomy.Conclusions:This study presents the first deep characterization of the proteome of NEPC and suggests that concomitant inhibition of REST and the p53 pathway would promote NEPC. We also identify SCGN as a novel prognostic marker in prostate cancer.